POSaBIT Systems Corporation, the cannabis point of sale and payments company (CSE: PBIT, OTC: POSAF), reported POSaBIT Q3 2026 results on 12 November 2026, showing revenue of $2,313,606 for the quarter ended 30 September 2026, down 2% from $2,363,061 a year earlier, while point of sale revenue rose 39% and the operating loss shrank to $122,692. Fintechbits checked POSaBIT’s material change report and found that the $1 million paid down in early September equals half of the $2 million of principal that its amended $4.75 million loan from Perga Capital Partners schedules over 18 months, with the interest rate falling to 9% on 1 January 2027. Lower costs carried the quarter, and licensing cash shrank.

POSaBIT Q3 2026 results: what the numbers show

In the POSaBIT Q3 2026 results, gross profit rose to $2,020,911, about 5% higher, and gross margin widened to 87% from 81% because cost of goods sold fell to $292,695 from $447,306. The release headline says gross profit grew 6%, but its own table computes 5%, and Fintechbits uses the table. Operating costs dropped to $2,143,603 from $2,426,612, and the net loss narrowed to $118,328 from $596,361.

The adjusted figures are weaker. Adjusted EBITDA, which adds back cash received from licensing contracts, was $638,776. The second-quarter release put the same measure at $1,081,265, so it fell 41% quarter over quarter even as the reported loss narrowed. Licensing cash receipts were $863,871 against $1,537,500 in the second quarter, a 44% drop.

Cash stood at about $2.9 million on 30 September 2026, against $3.34 million on 30 June 2026 and $1.2 million on 30 September 2025. Before the $1 million paydown, POSaBIT says cash would have been about $3.9 million. Chief executive Ryan Hamlin said growth in point of sale expands recurring software fees, which “reduces risk to the business and makes our forecast more predictable,” a fair point for software fees that does not describe licensing receipts.

Q2 guidance check: the MCP server shipped, growth slowed

On 20 August 2026, in its second-quarter release, Hamlin said, “We have several AI initiatives coming to market in the coming months, including a full MCP server for vendors and retailers.” The release for the POSaBIT Q3 2026 results, published 84 days later, says the server shipped in the quarter alongside a refreshed merchant portal. POSaBIT’s own launch release is dated 5 November 2026, 77 days after the guidance and 36 days after the quarter closed, and describes the portal change as a redesign with no change to functionality. The named product promise was kept, but the quarter label is loose.

Growth is where delivery fell short. Point of sale revenue growth slowed from 64% in the second quarter to 39% in the third, and the Q3 release gives no dollar figure for that line, so the base is hard to size. The Brand Portal claim is also unchanged: both releases say most of Washington’s top cannabis brands are live, which adds no new adoption number.

Loan terms in the September 2026 filing

The material change report, dated 3 September 2026, covers an amendment signed on 2 September 2026. The loan’s maturity moves from 31 March 2028 to 31 March 2030, and after the first date the balance amortises through monthly payments over 24 months. The rate falls from 12% to 10%, then to 9% from 1 January 2027.

Perga is a related party under Canada’s MI 61-101, so the amendment was exempt from formal valuation and minority shareholder approval, and the board approved it unanimously. The filing also says the size of the third scheduled prepayment depends on a tax refund. Fintechbits covered the refinancing on 9 September 2026 in its earlier loan analysis. The release does not state the principal left after the paydown, so Fintechbits does not put a figure on it.

Why the POSaBIT Q3 2026 results matter

The POSaBIT Q3 2026 results show a small cannabis vendor narrowing its loss through cost control and software fees while growth cooled. Total revenue fell by 2%, licensing cash fell by 44%, and the 39% point of sale gain is a slowdown from 64%. For retailers, the MCP server is a real change, since it lets them query their own data through AI tools.

For rivals, POSaBIT is spending cash on debt rather than on expansion beyond Washington, where it claims a dominant retailer footprint. For regulators, nothing changed. The DEA’s 28 April 2026 final rule covers FDA-approved products and state-licensed medical marijuana, and its chief administrative law judge paused the wider proceeding on 29 September 2026, according to law firm Ogletree Deakins. Merchants comparing what cashless acceptance costs in other sectors can read Fintechbits’ card acceptance costs interviews.

Frequently asked questions

What were the POSaBIT Q3 2026 results?

The POSaBIT Q3 2026 results list revenue of $2,313,606, down 2% from $2,363,061, with gross profit of $2,020,911 and a net loss of $118,328. Point of sale revenue rose 39% year over year. Adjusted EBITDA, a non-IFRS measure, was $638,776.

How much does POSaBIT still owe Perga Capital Partners?

The filing describes a $4.75 million loan as at the 2 September 2026 amendment. POSaBIT then paid $1 million in early September, but the Q3 release does not give the remaining balance, so it is unconfirmed.

Is POSaBIT’s adjusted EBITDA comparable with reported profit?

Not directly. In the POSaBIT Q3 2026 results, unadjusted EBITDA was a loss of $86,934, and the $638,776 adjusted figure adds $863,871 of licensing cash receipts while deducting licensing support revenue and interest income. The measure is the company’s own definition.

What to Watch Next

Four dates and numbers will show whether the POSaBIT Q3 2026 results hold. The rate steps down to 9% on 1 January 2027, monthly amortisation begins in April 2028 according to the filing, licensing cash receipts need to stabilise above $863,871, and point of sale growth needs to hold near 39%. A ruling from the DEA judge on the GAO report is the outside variable.